Cargando…

Hypoxia Impairs NK Cell Cytotoxicity through SHP-1-Mediated Attenuation of STAT3 and ERK Signaling Pathways

Natural killer (NK) cells are innate immune effectors with potent antitumor activity. However, tumor cells can create an immunosuppressive microenvironment to escape immune surveillance. Although accumulating evidence indicates that microenvironmental hypoxia plays an important role in favoring tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teng, Rui, Wang, Yanmeng, Lv, Nan, Zhang, Dan, Williamson, Ramone A., Lei, Lei, Chen, Ping, Lei, Li, Wang, Baiyan, Fu, Jiaqi, Liu, Xuna, He, Aili, O'Dwyer, Michael, Hu, Jinsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584946/ https://www.ncbi.nlm.nih.gov/pubmed/33123602 http://dx.doi.org/10.1155/2020/4598476

Ejemplares similares

Corrigendum to “Hypoxia Impairs NK Cell Cytotoxicity through SHP-1-Mediated Attenuation of STAT3 and ERK Signaling Pathways”
por: Teng, Rui, et al.
Publicado: (2021)

A novel CD2 staining–based flow cytometric assay for assessment of natural killer cell cytotoxicity
por: Zhang, Dan, et al.
Publicado: (2020)

Cell cycle exit during bortezomib‐induced osteogenic differentiation of mesenchymal stem cells was mediated by Xbp1s‐upregulated p21(Cip1) and p27(Kip1)
por: Zhang, Dan, et al.
Publicado: (2020)

ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
por: Zhang, Dan, et al.
Publicado: (2020)

Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells
por: Niogret, Charlène, et al.
Publicado: (2019)

shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
por: Subrakova, V.G., et al.
Publicado: (2020)

Inhibition of SHP-1 activity by PKC-θ regulates NK cell activation threshold and cytotoxicity
por: Ben-Shmuel, Aviad, et al.
Publicado: (2022)

SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer
por: Huang, Yan, et al.
Publicado: (2017)

Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development
por: Deng, Rong, et al.
Publicado: (2015)

Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia
por: Gurney, Mark, et al.
Publicado: (2021)

STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
por: Kang, Yu Hui, et al.
Publicado: (2019)

CD86 Is an Activation Receptor for NK Cell Cytotoxicity against Tumor Cells
por: Peng, Yanmeng, et al.
Publicado: (2013)

Sorafenib analogue SC‐60 induces apoptosis through the SHP‐1/STAT3 pathway and enhances docetaxel cytotoxicity in triple‐negative breast cancer cells
por: Liu, Chun‐Yu, et al.
Publicado: (2017)

Hypoxia-Driven HIF-1α Activation Reprograms Pre-Activated NK Cells towards Highly Potent Effector Phenotypes via ERK/STAT3 Pathways
por: Lim, Seon Ah, et al.
Publicado: (2021)

SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors
por: Ahmed, Tamer A., et al.
Publicado: (2019)

Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1
por: Su, Jung-Chen, et al.
Publicado: (2018)

Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
por: Sarkar, Subhashis, et al.
Publicado: (2013)

Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018)

STAT1 Ser727 – key regulator for NK cell-mediated cytotoxicity and tumor surveillance
por: Putz, Eva M, et al.
Publicado: (2008)

Inhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer
por: Koh, Jin Sung, et al.
Publicado: (2018)

Protein Tyrosine Phosphatases, TC-PTP, SHP1, and SHP2, Cooperate in Rapid Dephosphorylation of Stat3 in Keratinocytes Following UVB Irradiation
por: Kim, Dae Joon, et al.
Publicado: (2010)

Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity
por: Natoni, Alessandro, et al.
Publicado: (2023)

P861: SIALOFUCOSYLATED STRUCTURES ENABLE PLATELET BINDING TO MYELOMA CELLS CONFERRING PROTECTION FROM NK-MEDIATED CYTOTOXICITY
por: Natoni, A., et al.
Publicado: (2022)

CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
por: Putz, Eva Maria, et al.
Publicado: (2013)

Glucosamine prevents polarization of cytotoxic granules in NK-92 cells by disturbing FOXO1/ERK/paxillin phosphorylation
por: Božič, Janja, et al.
Publicado: (2018)

Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma
por: Beldi-Ferchiou, Asma, et al.
Publicado: (2017)

Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer()()
por: Fan, Li-Ching, et al.
Publicado: (2015)

SHP2 participates in decidualization by activating ERK to maintain normal nuclear localization of progesterone receptor
por: Chen, Lin, et al.
Publicado: (2023)

SHP-1/STAT3 Interaction Is Related to Luteolin-Induced Myocardial Ischemia Protection
por: Liu, Donghai, et al.
Publicado: (2021)

Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1
por: Song, Shiyu, et al.
Publicado: (2017)

Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition
por: Yang, Li, et al.
Publicado: (2017)

Correction: Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1
por: Song, Shiyu, et al.
Publicado: (2018)

Isovitexin Inhibits Ginkgolic Acids-Induced Inflammation Through Downregulating SHP2 Activation
por: Zhang, Yiwei, et al.
Publicado: (2021)

Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3
por: Qi, Chen, et al.
Publicado: (2017)

Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma
por: Hu, Ming-Hung, et al.
Publicado: (2017)

Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy
por: Huang, Tzu-Ting, et al.
Publicado: (2017)

SHP2 inhibitor PHPS1 ameliorates acute kidney injury by Erk1/2-STAT3 signaling in a combined murine hemorrhage followed by septic challenge model
por: Jiang, Jihong, et al.
Publicado: (2020)

Escin Sodium Improves the Prognosis of Acute Pancreatitis via Promoting Cell Apoptosis by Suppression of the ERK/STAT3 Signaling Pathway
por: Zhang, Qian, et al.
Publicado: (2021)

STATs in NK-Cells: The Good, the Bad, and the Ugly
por: Gotthardt, Dagmar, et al.
Publicado: (2017)

Treg-specific deletion of the phosphatase SHP-1 impairs control of inflammation in vivo
por: Gu, QinLei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vjneskudj6udl83oqd2dp0ih8u